advisorsecurities master

AURAAura Biosciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
12061
Ticker
AURA
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-10-29
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
AURA

Detail

Enriched 2026-08-14 20:47

Market cap
$801,632,224
Shares outstanding (class)
103,436,416
Shares outstanding (weighted)
103,436,416
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
113
Location
BOSTON, MA
Description

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data